## Correct Answer: D. Endometrial cancer Postmenopausal bleeding (PMB) is an alarm symptom for endometrial malignancy until proven otherwise. In a 65-year-old postmenopausal woman presenting with vaginal bleeding, endometrial cancer is the most likely diagnosis and the key discriminator. The incidence of endometrial cancer increases sharply after menopause due to unopposed estrogen stimulation (especially in obese women with peripheral aromatization of androgens to estrogen). PMB occurs in 90% of early-stage endometrial cancer cases, making it the cardinal presenting symptom. The decision to perform total hysterectomy in this clinical context reflects the standard surgical management (TAH-BSO ± staging) for confirmed or highly suspected endometrial malignancy. While adenomyosis, fibroids, and endometriosis can cause abnormal uterine bleeding in reproductive-age women, they do not typically present with PMB. In the Indian context, where screening programs are limited and many women present late, PMB remains the most important red flag for endometrial pathology. The age (65 years, clearly postmenopausal) and symptom (bleeding) together make endometrial cancer the most likely diagnosis requiring hysterectomy as definitive management. ## Why the other options are wrong **A. Adenomyosis** — Adenomyosis is a disease of reproductive-age and perimenopausal women, characterized by dysmenorrhea and menorrhagia during reproductive years. It typically causes heavy menstrual bleeding, not postmenopausal bleeding. In a 65-year-old postmenopausal woman, adenomyosis is unlikely to be the primary diagnosis. While adenomyosis may coexist with endometrial cancer, it is not the most likely diagnosis in this age group presenting with PMB. **B. Fibroid** — Uterine fibroids (leiomyomas) are common in reproductive-age women and can cause heavy menstrual bleeding and dysmenorrhea. However, fibroids typically regress after menopause due to loss of estrogen stimulation. Postmenopausal bleeding from fibroids alone is uncommon; if PMB occurs in a woman with known fibroids, malignancy must be excluded. Fibroids do not explain PMB in a 65-year-old unless malignancy coexists. **C. Endometriosis** — Endometriosis is a disease of reproductive-age women (peak incidence 30–40 years) and typically regresses after menopause due to estrogen withdrawal. It causes dysmenorrhea, dyspareunia, and infertility, not postmenopausal bleeding. Endometriosis is extremely rare in postmenopausal women and would not be the most likely diagnosis in a 65-year-old with PMB. It is not an indication for hysterectomy in this clinical scenario. ## High-Yield Facts - **Postmenopausal bleeding** is endometrial cancer until proven otherwise; occurs in ~90% of early-stage cases. - **Age >60 years** and **obesity** are major risk factors for endometrial cancer due to unopposed estrogen. - **Adenomyosis, fibroids, and endometriosis** are diseases of reproductive/perimenopausal women; they regress after menopause. - **TAH-BSO (total abdominal hysterectomy with bilateral salpingo-oophorectomy)** is standard surgical management for endometrial cancer. - **Endometrial biopsy or D&C** is the diagnostic gold standard for PMB; imaging (TVS) is initial screening in India. ## Mnemonics **PMB RED FLAGS** **P**ostmenopausal bleeding = **R**ed flag for **E**ndometrial **D**isease (cancer). Always exclude malignancy first in any woman with PMB, regardless of other symptoms. **Age-Related Benign Bleeding Causes** **Adenomyosis, Fibroids, Endometriosis** → **Reproductive/Perimenopausal age**. Once postmenopausal → think **Malignancy** (endometrial cancer, cervical cancer, vaginal atrophy). ## NBE Trap NBE may pair adenomyosis or fibroids with postmenopausal bleeding to trap students who recall these as common causes of abnormal uterine bleeding in general, without recognizing that PMB in a postmenopausal woman is a red flag for malignancy, not benign pathology. ## Clinical Pearl In Indian clinical practice, many women present late with endometrial cancer because PMB is often attributed to benign causes (fibroids, atrophy) without proper investigation. Any postmenopausal woman with bleeding should undergo endometrial biopsy or TVS-guided assessment; hysterectomy is curative if caught early, but delayed diagnosis leads to advanced-stage disease with poor outcomes. _Reference: DC Dutta's Textbook of Gynaecology (6th ed.), Ch. 12 (Endometrial Cancer); OP Ghai's Essential Obstetrics (9th ed.), Ch. 18 (Postmenopausal Bleeding)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.